Paradigm Biopharmaceuticals | PAR - Ebitda

Stock Price
0.19
Daily Change
-0.04 -15.56%
Monthly
-26.92%
Yearly
-38.71%
Q2 Forecast
0.22

Paradigm Biopharmaceuticals reported AUD-5.86M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Avita Medical AUD -9.69M 12.21M Dec/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Pacific Edge NZD -13.97M 332K Sep/2024
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025